Eli Lilly Canada Inc. v. Teva Canada Limited, 2021 FCA 129 (Tadalafil*)
Justice Rennie - 2021-06-29
Read full decision. Automatically generated summary:
The respondent Teva Canada Limited moves for an order precluding the appellants Eli Lilly Canada Inc., Eli Lilly and Company, Lilly Del Caribe, Inc., Lilly, S.A., and ICOS Corporation from referring to UK 1,404,340 Patent (UK patent) in their memorandum of fact and law, including the UK patent in the joint book of authorities or placing the UK patent before the panel hearing the appeal. [see 2021 FCA 127]
Decision relates to:
- A-238-20 - ELI LILLY INC. ET AL v. TEVA CANADA LIMITED which is an appeal from 2020 FC 816 in T-1631-16